Get the latest news and updates on FINTECH.TV Skye Bioscience’s Developing Treatment for Glaucoma Daily Download February 22, 2023 Share FacebookTwitterPinterestWhatsApp Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves. Related posts: Speculation Growing Over Uses for ChatGPT AI Sweater Aiming to Make Venture Capital More Accessible SEC Cracks Down on Kraken Exploring The Future Of The Metaverse Advertisement Latest articles What is an ISO? Breaking Down the Payments Middlemen You Never See Taking Stock March 3, 2026 Donaldson’s Leadership Transition & 2026 Outlook Taking Stock March 3, 2026 Market Reversal After Geopolitical Shock: Oil, Inflation & What’s Next Taking Stock March 3, 2026 Elias Haddad on The Dollar’s Safe Haven Surge Amid Middle East Tensions Market Movers: The Opening Bell March 2, 2026 Related articles What is an ISO? Breaking Down the Payments Middlemen You Never See Taking Stock March 3, 2026 Donaldson’s Leadership Transition & 2026 Outlook Taking Stock March 3, 2026 Market Reversal After Geopolitical Shock: Oil, Inflation & What’s Next Taking Stock March 3, 2026